This test is most useful if any of these apply to you.
Mesquite pollen can cause hay fever, itchy eyes, and allergic asthma. If your symptoms coincide with its flowering season, this test can help identify a possible trigger. The season varies by location, so a spring pattern isn't required everywhere.
Serum allergen-specific IgE testing is an established part of allergy assessment. Its value comes from connecting an antibody result with your symptoms and exposure. A positive result alone doesn't establish that mesquite is causing your symptoms.
IgE is a type of antibody involved in immediate allergic reactions. It attaches to immune cells that can release histamine and other chemicals when an allergen binds to it. These chemicals contribute to sneezing, itching, and airway symptoms.
This test measures IgE in serum that binds to pollen extract from Prosopis juliflora. Serum is the liquid remaining after blood clots. A quantitative antibody assay reports the concentration in kU/L. The result combines binding to proteins and other structures in the pollen extract; it doesn't identify each individual protein your antibodies recognize.
Detectable allergen-specific IgE indicates sensitization. You can be sensitized without having symptoms when exposed. The concentration also cannot reliably predict how severe your hay fever or an asthma attack will be.
Mesquite pollen contains several allergenic proteins. In an Indian study, research assays using serum from sensitized people identified IgE binding to 16 pollen proteins. Several were recognized by most of the people studied. This work helps explain the complexity of the pollen extract, but it didn't establish a protein pattern that predicts symptom severity.
Mesquite's ability to cause allergic symptoms has been demonstrated through supervised exposure. In an older US allergy-clinic study, 62 of 100 adults reacted on skin testing. An earlier blood-antibody assay supported IgE sensitization, and nasal, eye, and airway challenges showed that mesquite could provoke allergic reactions. The researchers also detected transported pollen despite the absence of mesquite within about 50 miles.
A study of 628 people with allergic rhinitis in Mexico found positive mesquite skin tests in about 21%. In India, 71 of 220 people with respiratory allergies reacted to mesquite on intradermal testing. These figures describe skin-test sensitization in selected clinical populations, so they aren't estimates of how often this serum test will be positive in the general population.
In a Kuwaiti study, mesquite-specific serum IgE was detected in about 63% of the 482 participants who had asthma and at least one positive inhalant-allergen test. Mesquite ranked behind goosefoot and Bermuda grass among the pollens tested. That percentage applies to the sensitized subgroup, not everyone with asthma.
A positive result becomes more informative when wheezing, coughing, or chest tightness repeatedly coincides with likely mesquite exposure. Other pollens can circulate at the same time, and several triggers may contribute. The antibody result helps assess a possible allergic trigger; asthma diagnosis and control require their own clinical assessment.
Mesquite sensitization varies across regions. A Mexican study found lower odds of a positive mesquite skin test in humid regions than in dry regions. It compared different groups of people and didn't measure how moving to a dry climate changes someone's serum IgE.
Regional differences were also large in a Saudi study of people attending allergy and chest clinics. Positive mesquite skin tests ranged from about 11% in Hofuf to 76% in Qassim. Many participants reacted to other pollens too. Local vegetation and flowering seasons help interpret a result, but geography alone cannot identify which pollen causes your symptoms.
An IgE antibody can recognize similar structures in more than one plant. Laboratory studies using human serum have found cross-reactivity between mesquite and acacia pollen, as well as Ailanthus, Senna, and Salvadora. This can contribute to positive results for several plants even when the original sensitizing exposure is unclear.
Laboratory experiments have also found shared IgE binding between mesquite pollen and lima bean proteins. Those experiments demonstrate antibody cross-reactivity. They don't establish that everyone with mesquite sensitization will react when eating lima beans.
Pollen sensitization can persist for years. A Swedish study followed children into adulthood and found that childhood sensitization to birch or grass was associated with later pollen-related rhinitis. It measured antibodies to those pollens, so it doesn't provide a mesquite-specific forecast.
For mesquite, there is no validated change in serum IgE that establishes improvement, worsening, or a need to change treatment. Your symptom pattern, medication needs, and asthma control carry more weight than the direction of this number alone.
Mesquite Tree IgE is best interpreted alongside these tests.
Mesquite Tree IgE is included in these pre-built panels.
See exactly which airborne triggers your body reacts to, so your sneezing, congestion, and wheezing finally have names.
See a wide map of the foods and airborne triggers your immune system reacts to, so you can stop guessing what sets off your symptoms.
80 biomarkers